Samsung Medison has announced a new partnership with the US medical technology company HistoSonics. This partnership aims to improve the way doctors find and treat cancer using ultrasound technology.

As per this collaboration, Samsung Medison will connect its advanced ultrasound imaging machine, the Samsung Medison R20 ultrasound system, with HistoSonics’ treatment device, the Edison histotripsy system. This connection will allow doctors to view clear ultrasound images while the treatment is taking place.

The Edison system uses a special treatment method known as Histotripsy. This method focuses powerful ultrasound waves on a tumor. These waves create tiny bubbles in the tumor tissue. When the bubbles quickly form and collapse, they break down and destroy the tumor cells.

A major benefit of this treatment is that it does not require surgery. Doctors do not need to make any cuts in the body. Because the treatment is noninvasive, patients may feel less pain and recover faster compared to traditional surgery.

There’s also an advantage that doctors can watch the treatment area through ultrasound images during the procedure. This helps them guide the treatment more precisely and avoid damaging nearby healthy tissue.

Both companies believe that combining imaging and treatment technologies will help create new opportunities in ultrasound-based cancer care. Yu Gyu-tae, head of Samsung Medison, said the partnership is an important step toward connecting diagnosis and treatment and will help the company expand its role in the global medical technology market.

The post Samsung Medison teams up with US HistoSonics to advance treatment appeared first on Sammy Fans.